Value of Cantrixil, page-2

First 2 Last

Share
Profile

Follow
cane7

4,133 Posts.

275

15/08/19

19:58

Post #: 40008421
Share

Originally posted by RBx: ↑

Harvett, how much do you think a partner would be willing to pay for Cantrixil?

A search will show that the Cantrixil Phase 1 abstract has been accepted as a poster presentation at ESMO in September, but unfortunately it looks like the data was not good enough to warrant an oral presentation. Kazia will need to find a way to separate itself from a pack of thousands if it is to land a partnership deal at ESMO.

A prospective partner would know that Kazia is in effect a stressed seller, needing the funds to progress GDC-0084. Ironically, Kazia needs someone like itself (when it had the money) who would be willing to take Cantrixil through Phase II.

As a number of posters have said, it is a good thing that some prestigious institutions are using GDC-0084 in clinical trials. The downside is that these institutions own the data and will release it at a time of their choosing, probably at major conferences, which may be too late to boost the share price before a CR is necessary.

We are getting to a critical point. Kazia needs funds but prospective lenders will wonder how they could sell any shares issued as part of a PIPE. Data from Part B of the Cantrixil trial will take time to mature, and so Kazia may be dependant on GDC-0084 data, which will have to be good, and known before funds run out.

The share price remains in the doldrums because of uncertainty about finance, in my opinion. It would be a brave person who bought at these levels, when the likelihood is that the SP will drop when a funding deal is announced.

Let’s hope JG can pull a rabbit out of his hat.

Expand

Well done mate! i have passed it on to JG, thanks

KZA Price at posting: 37.0¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

IMR

Imricor raises $35M to pursue growth and expansion into Australia and NZ

FG1

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

Talking Australia's very competitive property landscape: Realty Talks

MCT

Metalicity looking for offers on Admiral Bay zinc project

GNX

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

LKE

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

AI stocks: What to expect in 2024-25

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

There are more pages in this discussion • 25 more messages in this thread...

First 2 Last

Add KZA (ASX) to my watchlist

Value of Cantrixil, page-2

Top Stories

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

Imricor raises $35M to pursue growth and expansion into Australia and NZ

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

Talking Australia's very competitive property landscape: Realty Talks

Metalicity looking for offers on Admiral Bay zinc project

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

AI stocks: What to expect in 2024-25

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

Featured News